Zealand Pharma A/S | ZEAL - Selling And Administration Expenses

Stock Price
291.70
Daily Change
-2.30 -0.78%
Monthly
-20.58%
Yearly
-37.38%
Q1 Forecast
273.20

Zealand Pharma A/S reported 91.81M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Akebia Therapeutics USD 23.53M 3.19M Dec/2025
Alaunos Therapeutics USD 585K 84K Sep/2025
Avita Medical AUD 19.03M 1.95M Dec/2025
Dianthus Therapeutics USD 6.57M 1.62M Dec/2025
Ionis Pharmaceuticals USD 130M 43.43M Dec/2025
IQVIA Holdings USD 468M 46M Dec/2025
Moderna USD 308M 40M Dec/2025
Organon & Co USD 399M 54M Sep/2025
Revvity USD 251.73M 9.82M Dec/2025
Tectonic Therapeutic USD 3.44M 1.52M Dec/2025
Tilray USD 24.85M 1.7M Sep/2025
Viatris USD 1.03B 144.1M Dec/2025
Xeris Pharmaceuticals USD 42.64M 3.82M Dec/2025
Zealand Pharma A/S 91.81M 99.04M Dec/2025